56 related articles for article (PubMed ID: 24519041)
21. Individualized targeted therapy for glioblastoma: fact or fiction?
Weller M; Stupp R; Hegi M; Wick W
Cancer J; 2012; 18(1):40-4. PubMed ID: 22290256
[TBL] [Abstract][Full Text] [Related]
22. Monoclonal antibodies in gastrointestinal cancers.
Bronte G; Cicero G; Cusenza S; Galvano A; Musso E; Rizzo S; Sortino G; Roselli M; Bazan V; Fiorentino E; Russo A
Expert Opin Biol Ther; 2013 Jun; 13(6):889-900. PubMed ID: 23441760
[TBL] [Abstract][Full Text] [Related]
23. Proteomic approach toward personalized sarcoma treatment: lessons from prognostic biomarker discovery in gastrointestinal stromal tumor.
Kondo T; Suehara Y; Kikuta K; Kubota D; Tajima T; Mukaihara K; Ichikawa H; Kawai A
Proteomics Clin Appl; 2013 Jan; 7(1-2):70-8. PubMed ID: 23281253
[TBL] [Abstract][Full Text] [Related]
24. MicroRNAs as potential target gene in cancer gene therapy of gastrointestinal tumors.
Tazawa H; Kagawa S; Fujiwara T
Expert Opin Biol Ther; 2011 Feb; 11(2):145-55. PubMed ID: 21219233
[TBL] [Abstract][Full Text] [Related]
25. Gene therapy for gastrointestinal tract cancer: a review.
Heideman DA; Gerritsen WR; Craanen ME
Scand J Gastroenterol Suppl; 2000; (232):93-100. PubMed ID: 11232500
[TBL] [Abstract][Full Text] [Related]
26. Current status and problems in development of molecular target agents for gastrointestinal malignancy in Japan.
Boku N
Jpn J Clin Oncol; 2010 Mar; 40(3):183-7. PubMed ID: 20047861
[TBL] [Abstract][Full Text] [Related]
27. Future diagnostic and therapeutic trends in endocrine cancers.
Spiegel AM; Libutti SK
Semin Oncol; 2010 Dec; 37(6):691-5. PubMed ID: 21167386
[TBL] [Abstract][Full Text] [Related]
28. Gastrointestinal stromal tumors (GIST).
Landi B; Bouche O; Blay JY
Gastroenterol Clin Biol; 2006 Sep; 30 Spec No 2():2S98-2S101. PubMed ID: 17151569
[No Abstract] [Full Text] [Related]
29. [Metastatic brain tumors from gastrointestinal cancer: an analysis of patient background and treatment results].
Mizokami Y; Mitsuya K; Hayashi N; Yasui H; Harada H; Nishimura T; Nakasu Y
No Shinkei Geka; 2013 Aug; 41(8):669-77. PubMed ID: 23907473
[TBL] [Abstract][Full Text] [Related]
30. Novel ways to sensitise gastrointestinal cancer to apoptosis.
Schulze-Bergkamen H; Weinmann A; Moehler M; Siebler J; Galle PR
Gut; 2009 Jul; 58(7):1010-24. PubMed ID: 19520891
[TBL] [Abstract][Full Text] [Related]
31. [New perspectives in diagnosis and therapy of endocrine gastroenteropancreatic (GEP) tumors with somatostatin analogues].
Rubello D; Rufini V; De Carlo E; Martini C; Calcagni ML; Sicolo N; Troncone L; Casara D
Minerva Endocrinol; 2003 Dec; 28(4):259-96. PubMed ID: 14752399
[TBL] [Abstract][Full Text] [Related]
32. ERCC1: impact in multimodality treatment of upper gastrointestinal cancer.
Metzger R; Bollschweiler E; Hölscher AH; Warnecke-Eberz U
Future Oncol; 2010 Nov; 6(11):1735-49. PubMed ID: 21142660
[TBL] [Abstract][Full Text] [Related]
33. Microarrays in gastrointestinal cancer: is personalized prediction of response to chemotherapy at hand?
Jensen EH; McLoughlin JM; Yeatman TJ
Curr Opin Oncol; 2006 Jul; 18(4):374-80. PubMed ID: 16721134
[TBL] [Abstract][Full Text] [Related]
34. New concepts of staging in gastrointestinal tumors as a basis of diagnosis and multimodal therapy.
Gretschel S; Moesta KT; Hünerbein M; Lange T; Gebauer B; Stroszczinski C; Bembenek A; Schlag PM
Onkologie; 2004 Feb; 27(1):23-30. PubMed ID: 15007245
[TBL] [Abstract][Full Text] [Related]
35. Gastrointestinal carcinoid tumors: diagnosis and treatment.
Stamatakos M; Kontzoglou K; Sargedi C; Tsaknaki S; Iannescu R; Safioleas C; Kaitanidi V; Safioleas M
Chirurgia (Bucur); 2010; 105(6):759-66. PubMed ID: 21351698
[TBL] [Abstract][Full Text] [Related]
36. Primary leiomyosarcomas of the gastrointestinal tract in the post-gastrointestinal stromal tumor era.
Aggarwal G; Sharma S; Zheng M; Reid MD; Crosby JH; Chamberlain SM; Nayak-Kapoor A; Lee JR
Ann Diagn Pathol; 2012 Dec; 16(6):532-40. PubMed ID: 22917807
[TBL] [Abstract][Full Text] [Related]
37. [Possibilities and limitations of stratified medicine based on biomarkers and targeted therapies in oncology].
Ludwig WD
Z Evid Fortbild Qual Gesundhwes; 2012; 106(1):11-22. PubMed ID: 22325103
[TBL] [Abstract][Full Text] [Related]
38. Personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
[TBL] [Abstract][Full Text] [Related]
39. Perspectives of clinical proteomics in gastrointestinal cancer.
Ebert M; Xing X; Burgermeister E; Schmid R; Röcken C
Expert Rev Anticancer Ther; 2007 Apr; 7(4):465-9. PubMed ID: 17428167
[TBL] [Abstract][Full Text] [Related]
40. Endogenous stimulators and inhibitors of angiogenesis in gastrointestinal cancers: basic science to clinical application.
Sund M; Zeisberg M; Kalluri R
Gastroenterology; 2005 Dec; 129(6):2076-91. PubMed ID: 16344073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
